2017 Imprinting of Pharmaceuticals

Authors:
Munawar Hussain*, Hans P Wendel and Frank K Gehring


Journal:
Int J Pharma Anal Acta. 2017;1(1): 013-014., 20 January, 2020

Institut:

Biosensor Research Group, Thoracic, Cardiac and Vascular Surgery Department, Tuebingen University, Germany

*Address for Correspondence:Biosensor Research Group, Thoracic, Cardiac and Vascular Surgery Department, Tuebingen University, Germany,

Abstract:

Molecular imprinting technology is promising for pharmaceutical applications for instance, separation, extraction, quantitative analysis, qualitative analysis, screening, delivery and targeting of medicines or their  metabolites.  Th   e  literature  demonstrates  similar  or  sometimes  even higher selectivity on comparing with those of natural antibodies. Achieving selectivity is still challenging [1], because natural antibodies are  generated  in  nature  via  “induced  fi  t”  mechanism  along  with  the  natural optimization of the analyte-receptor interaction [2].